Core Viewpoint - PharmaCorp RX Inc. has filed a preliminary short form base shelf prospectus to qualify the distribution of up to $100 million in various securities over a 25-month period, enhancing its ability to access capital markets for growth and acquisitions [2][3]. Company Overview - PharmaCorp is a Canadian pharmacy acquisition and ownership platform focused on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners [5]. - The company operates four pharmacies under the PharmaChoice Canada banner and aims to acquire more pharmacies, rebranding them under its platform [5]. Financial Strategy - The base shelf prospectus will allow PharmaCorp to issue common shares, preferred shares, warrants, debt securities, subscription receipts, units, or any combination thereof, based on financial requirements and market conditions [2]. - The specific terms of any offerings will be detailed in prospectus supplements filed with Canadian securities regulatory authorities [2]. Corporate Development - The filing of the base shelf prospectus is seen as a milestone in PharmaCorp's corporate development, providing flexibility to access capital markets as acquisition opportunities arise [3]. - The strategic alliance with PharmaChoice Canada is highlighted as a key factor in advancing the company's national growth and operations platform [3].

Core Insights - Reflect Scientific, Inc. is transitioning from the OTCQB Venture Market to the OTCIQ platform to enhance regulatory compliance and investor communication [1][2] - The move to OTCIQ reflects the company's commitment to transparency, growth, and long-term shareholder value, providing a centralized environment for corporate disclosures and improved reporting consistency [2][3] - CEO Kim Boyce stated that this strategic step aims to strengthen visibility and accessibility while expanding the investor base, positioning the company for its next development phase [3] Company Overview - Reflect Scientific, Inc. is based in Orem, Utah, and specializes in innovative cryogenic technologies for the biotechnology, pharmaceutical, medical, and transportation markets [4] - The company develops advanced cryogenic systems, including ultra-low temperature freezers used in pharmaceutical research, vaccine storage, and other critical scientific applications [3][4]